3

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: February 26, 2004
Period of Report: February 26, 2004
Accession Number: 0001247741-04-000022

View Document ↗ View on SEC.gov ↗